MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Dienstmann R, Mason MJ, Sinicrope FA, et al. Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol. 2017 May 1;28(5):1023–1031.
   PubMed Web of Science ®Google Scholar
• Suenaga M, Akiyoshi T, Shinozaki E, et al. A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study. Anticancer Res. 2018 Mar;38(3):1741–1747.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang J, Li J. Role of miRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020 Jan;500:10–19.
   PubMed Web of Science ®Google Scholar
• Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009 Mar;11(3):228–234.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 9;435(7043):834–838.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhong YD, Zhao XX. MiR-548b suppresses proliferative capacity of colorectal cancer by binding WNT2. Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10535–10541.
   PubMed Web of Science ®Google Scholar
• Shirjang S, Mansoori B, Mohammadi A, et al. miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1. Adv Pharm Bull. 2020 Jul;10(3):444–451.
   PubMed Web of Science ®Google Scholar
• Wang K, Yan L, Lu F. miR-363-3p Inhibits Osteosarcoma Cell Proliferation and Invasion via Targeting SOX4. Oncol Res. 2019 Feb 5;27(2):157–163.
   PubMed Web of Science ®Google Scholar
• Bian WG, Zhou XN, Song S, et al. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A. Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):649–659.
   PubMed Web of Science ®Google Scholar
• Dong J, Geng J, Tan W. MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2. Biomed Pharmacother. 2018 Sep;105:922–931.
   PubMed Web of Science ®Google Scholar
• Marumoto T, Zhang D, Saya H. Aurora-A - a guardian of Poles. Nat Rev Cancer. 2005 Jan;5(1):42–50.
   PubMed Web of Science ®Google Scholar
• Zhong N, Shi S, Wang H, et al. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells. Int J Oncol. 2016 Sep;49(3):1028–1038.
   PubMed Web of Science ®Google Scholar
• Wu J, Yang L, Shan Y, et al. AURKA promotes cell migration and invasion of head and neck squamous cell carcinoma through regulation of the AURKA/Akt/FAK signaling pathway. Oncol Lett. 2016 Mar;11(3):1889–1894.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Z, Shen X, et al. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis. Mol Genet Genomic Med. 2019 Jul;7(7):e00713.
   PubMed Web of Science ®Google Scholar
• Jacobsen A, Bosch LJW, Martens-de Kemp SR, et al. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. Sci Rep. 2018 May 14;8(1):7522.
   PubMedGoogle Scholar
• Li C, Wang P, Du J, et al. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer. IUBMB Life. 2021 Jan;73(1):286–298.
   PubMed Web of Science ®Google Scholar
• Han Y, Wang X, Mao E, et al. lncRNA FLVCR1‑AS1 drives colorectal cancer progression via modulation of the miR‑381/RAP2A axis. Mol Med Rep. 2021 Feb;23(2):1.
   Web of Science ®Google Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012 Feb 15;482(7385):339–346.
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016 Apr 11;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Zhang M, Weng W, Zhang Q, et al. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol. 2018 Sep 5;11(1):113.
   PubMedGoogle Scholar
• Damas ND, Marcatti M, Côme C, et al. SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. 2016 Dec 22;7(1):13875.
   PubMedGoogle Scholar
• Li M, Zhang YY, Shang J, et al. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. Eur Rev Med Pharmacol Sci. 2019 May;23(10):4185–4191.
   PubMed Web of Science ®Google Scholar
• Ma Z, Xue S, Zeng B, et al. lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27. Oncol Lett. 2018 Feb;15(2):1924–1930.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Wang H, et al. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5. Cancer Biol Ther. 2019;20(4):524–536.
   PubMed Web of Science ®Google Scholar
• Liu D, Wang Y, Zhao Y, et al. LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis. BMC Cancer. 2020 Mar 4;20(1):178.
   PubMed Web of Science ®Google Scholar
• Li WZ, Zou Y, Song ZY, et al. Long non-coding RNA SNHG5 affects the invasion and apoptosis of renal cell carcinoma by regulating the miR-363-3p-Twist1 interaction. Am J Transl Res. 2020 Feb 15;12(2):697–707.
   PubMed Web of Science ®Google Scholar
• Hu PA, Miao YY, Yu S, et al. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-363-3p/RNF38 axis. Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3592–3604.
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20): 2191–2194.
   PubMed Web of Science ®Google Scholar
• Sun Y, Cao B, Zhou J. Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells. BMC Cancer. 2020 May 18;20(1):434.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001 May 1;29(9):e45.
   PubMed Web of Science ®Google Scholar
• Liu CH, Jing XN, Liu XL, et al. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1. J Ovarian Res. 2020 Aug 11;13(1):92.
   PubMed Web of Science ®Google Scholar
• Xu Y, Hou R, Lu Q, et al. MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer. Am J Cancer Res. 2017 Dec 1;7(12):2545–2553.
   PubMed Web of Science ®Google Scholar
• Zhou D, He Y, Li H, et al. Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition. Exp Ther Med. 2021 Jul;22(1):770.
   PubMed Web of Science ®Google Scholar
• Zhou B, Guo H, Tang J. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2. Med Sci Monit. 2019 Feb 15;25:1242–1253.
   PubMed Web of Science ®Google Scholar
• Shi DB, Ma RR, Zhang H, et al. GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer. J Exp Clin Cancer Res. 2019 Mar 11;38(1):124.
   PubMedGoogle Scholar
• Lei KF, Liu BY, Jin XL, et al. Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer. Exp Ther Med. 2012 Jun;3(6):993–998.
   PubMed Web of Science ®Google Scholar
• Cui H, Jiang Z, Zeng S, et al. A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer. Cell Death Dis. 2021 Oct 2;12(10):903.
   PubMed Web of Science ®Google Scholar
• Li SS, Zhu HJ, Li JY, et al. MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level. Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1126–1133.
   PubMed Web of Science ®Google Scholar
• Guo L, Fu J, Sun S, et al. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci. 2019 Feb;110(2):805–816.
   PubMed Web of Science ®Google Scholar
• Fu J, Bian M, Jiang Q, et al. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res. 2007 Jan;5(1):1–10.
   PubMed Web of Science ®Google Scholar
• Zhou N, Singh K, Mir MC, et al. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res. 2013 Apr 1;19(7):1717–1728.
   PubMed Web of Science ®Google Scholar
• Taylor NJ, Bensen JT, Poole C, et al. et al.Genetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtype. Mol Carcinog. 2015 Dec;54(12):1668–1677.
   PubMed Web of Science ®Google Scholar
• Cirak Y, Furuncuoglu Y, Yapicier O, et al. Aurora A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis. J BUON. 2015 Nov-Dec;20(6):1414–1419.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Sun T, Ye F, et al. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA. Cancer Biomark. 2017;19(1):93–101.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen Y, Tan L, et al. Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis. Heart Vessels. 2019 Aug;34(8):1370–1380.
   PubMed Web of Science ®Google Scholar
• Gomaa A, Peng D, Chen Z, et al. Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers. Sci Rep. 2019 Nov 18;9(1):16970.
   PubMedGoogle Scholar
• Zhi H, Lian J. LncRNA BDNF-AS suppresses colorectal cancer cell proliferation and migration by epigenetically repressing GSK-3β expression. Cell Biochem Funct. 2019 Jul;37(5):340–347.
   PubMed Web of Science ®Google Scholar
• Wang X, Lai Q, He J, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019 Jan 1;16(1):51–59.
   PubMed Web of Science ®Google Scholar
• Hu X, Hong Y, Shang C. Knockdown of long non-coding RNA SNHG5 inhibits malignant cellular phenotypes of glioma via Wnt/CTNNB1 signaling pathway. J Cancer. 2019 Jan 30;10(5):1333–1340.
   PubMed Web of Science ®Google Scholar
• Gao J, Zeng K, Liu Y, et al. LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 2018 Dec 24;12:169–179.
   PubMedGoogle Scholar